| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |